Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Paul Vigano Sells 1,000,000 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder Paul Vigano sold 1,000,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $8.00, for a total value of $8,000,000.00. Following the transaction, the insider owned 245,251 shares in the company, valued at $1,962,008. This represents a 80.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Aveanna Healthcare Trading Up 1.9%

AVAH opened at $8.64 on Friday. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.73 and a 52 week high of $10.32. The business’s 50 day moving average is $7.14 and its two-hundred day moving average is $7.58. The firm has a market cap of $1.88 billion, a price-to-earnings ratio of 7.32, a price-to-earnings-growth ratio of 0.88 and a beta of 1.93.

Get Aveanna Healthcare alerts:

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.05. The business had revenue of $647.91 million during the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The firm’s revenue was up 15.9% compared to the same quarter last year. On average, research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on AVAH shares. Weiss Ratings downgraded shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Truist Financial raised their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a report on Wednesday, May 20th. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price target on the stock in a research report on Wednesday, June 3rd. Finally, Barclays reduced their price objective on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Aveanna Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $10.50.

Read Our Latest Stock Analysis on AVAH

Institutional Trading of Aveanna Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in AVAH. Caitong International Asset Management Co. Ltd increased its stake in shares of Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the period. Summit Securities Group LLC acquired a new stake in Aveanna Healthcare in the first quarter valued at about $53,000. Quantbot Technologies LP purchased a new stake in Aveanna Healthcare in the 2nd quarter valued at approximately $43,000. EverSource Wealth Advisors LLC boosted its holdings in Aveanna Healthcare by 88,100.0% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock valued at $102,000 after purchasing an additional 11,453 shares in the last quarter. Finally, Entropy Technologies LP acquired a new position in Aveanna Healthcare during the 3rd quarter worth approximately $107,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Featured Stories

• Five stocks we like better than Aveanna Healthcare
• Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
• AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
• Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
• Xcel Energy Stock Offers Stability as Electricity Demand Builds

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.